Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice

PLoS Pathogens

Volumn 11, Issue 8, 2015, Pages

  Mitagami, Yu ^a   Yasunaga, Jun ichirou ^a   Kinosada, Haruka ^a   Ohshima, Koichi ^b   Matsuoka, Masao ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BETA1 INTEGRIN; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; P SELECTIN GLYCOPROTEIN LIGAND 1; PHYTOHEMAGGLUTININ; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MIGRATION ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOMODULATION; INFLAMMATION; INTESTINE FLORA; INTRINSIC ACTIVITY; LYMPHOMAGENESIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; ANIMAL; C57BL MOUSE; CELL TRANSFORMATION; DISEASE MODEL; HTLV-1 INFECTION; IMMUNOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; TRANSGENIC MOUSE; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS GENE;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENES, VIRAL; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFLAMMATION; INTERFERON-GAMMA; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION;

EID: 84940762783     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005120     Document Type: Article

References (51)

1. Matsuoka M, Yasunaga JI, Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor. Curr Opin Virol. 2013. Epub 2013/09/26. S1879-6257(13)00146-6 [pii] doi: 10.1016/j.coviro.2013.08.010 24060211.
2. Yasunaga J, Sakai T, Nosaka K, Etoh K, Tamiya S, Koga S, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood. 2001;97(10):3177–83. Epub 2001/05/09. 11342446.
3. Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M, HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals. Retrovirology. 2012;9(1):46. Epub 2012/06/01. doi: 10.1186/1742-4690-9-46 22647666.
4. Yamano Y, Sato T, Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Frontiers in microbiology. 2012;3:389. Epub 2012/11/20. doi: 10.3389/fmicb.2012.00389 23162542; PubMed Central PMCID: PMC3494083.
5. Kamoi K, Mochizuki M, HTLV-1 uveitis. Frontiers in microbiology. 2012;3:270. Epub 2012/07/28. doi: 10.3389/fmicb.2012.00270 22837757; PubMed Central PMCID: PMC3403349.
6. Goncalves DU, Guedes AC, Proietti AB, Martins ML, Proietti FA, Lambertucci JR, Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1. Am J Trop Med Hyg. 2003;68(5):562–5. Epub 2003/06/19. 12812346.
7. Kadota J, Mukae H, Fujii T, Seki M, Tomono K, Kohno S, Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest. 2004;125(4):1239–47. Epub 2004/04/14. 15078730.
8. Lee R, Schwartz RA, Human T-lymphotrophic virus type 1-associated infective dermatitis: a comprehensive review. J Am Acad Dermatol. 2011;64(1):152–60. Epub 2010/08/10. doi: 10.1016/j.jaad.2009.10.021 20691499.
9. Carvalho EM, Da Fonseca Porto A, Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite immunology. 2004;26(11–12):487–97. Epub 2005/03/18. doi: 10.1111/j.0141-9838.2004.00726.x 15771684.
10. Yamamoto M, Matsuyama W, Oonakahara K, Watanabe M, Higashimoto I, Kawabata M, et al. Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis. Clin Exp Immunol. 2004;136(3):513–20. Epub 2004/05/19. doi: 10.1111/j.1365-2249.2004.02485.x 15147354; PubMed Central PMCID: PMC1809062.
11. Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, et al. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. PLoS pathogens. 2013;9(4):e1003263. Epub 2013/04/18. doi: 10.1371/journal.ppat.1003263 23592987; PubMed Central PMCID: PMC3617147.
12. Matsuoka M, Jeang KT, Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7(4):270–80. Epub 2007/03/27. nrc2111 [pii] doi: 10.1038/nrc2111 17384582.
13. Satou Y, Yasunaga J, Yoshida M, Matsuoka M, HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A. 2006;103(3):720–5. Epub 2006/01/13. 0507631103 [pii] doi: 10.1073/pnas.0507631103 16407133; PubMed Central PMCID: PMC1334651.
14. Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004;109(4):559–67. Epub 2004/03/03. doi: 10.1002/ijc.20007 14991578.
15. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A, et al. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology. 2005;2:64. Epub 2005/10/26. 1742-4690-2-64 [pii] doi: 10.1186/1742-4690-2-64 16242045; PubMed Central PMCID: PMC1289293.
16. Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011;7(2):e1001274. Epub 2011/02/25. doi: 10.1371/journal.ppat.1001274 21347344; PubMed Central PMCID: PMC3037353.
17. Sugata K, Satou Y, Yasunaga J, Hara H, Ohshima K, Utsunomiya A, et al. HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood. 2012;119(2):434–44. Epub 2011/11/30. doi: 10.1182/blood-2011-05-357459 blood-2011-05-357459 [pii]. 22123848; PubMed Central PMCID: PMC3257009.
18. Yamamoto-Taguchi N, Satou Y, Miyazato P, Ohshima K, Nakagawa M, Katagiri K, et al. HTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression. PLoS Pathog. 2013;9(9):e1003630. Epub 2013/09/27. doi: 10.1371/journal.ppat.1003630 PPATHOGENS-D-13-01005 [pii]. 24068936; PubMed Central PMCID: PMC3777874.
19. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nature immunology. 2009;10(9):1000–7. Epub 2009/07/28. doi: 10.1038/ni.1774 19633673; PubMed Central PMCID: PMC2729804.
20. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337–41. Epub 2011/01/06. doi: 10.1126/science.1198469 21205640; PubMed Central PMCID: PMC3969237.
21. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA, Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259(5102):1739–42. Epub 1993/03/19. 8456300.
22. Groom JR, Luster AD, CXCR3 in T cell function. Exp Cell Res. 2011;317(5):620–31. Epub 2011/03/08. doi: 10.1016/j.yexcr.2010.12.017 21376175; PubMed Central PMCID: PMC3065205.
23. Luster AD, Unkeless JC, Ravetch JV, Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 1985;315(6021):672–6. Epub 1985/06/20. 3925348.
24. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD, IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. Journal of immunology. 2002;168(7):3195–204. Epub 2002/03/22. 11907072.
25. Coussens LM, Werb Z, Inflammation and cancer. Nature. 2002;420(6917):860–7. Epub 2002/12/20. doi: 10.1038/nature01322 12490959; PubMed Central PMCID: PMC2803035.
26. Langholz E, Munkholm P, Davidsen M, Binder V, Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103(5):1444–51. Epub 1992/11/01. 1358741.
27. Ernst PB, Gold BD, The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol. 2000;54:615–40. Epub 2000/10/06. doi: 10.1146/annurev.micro.54.1.615 11018139.
28. Shlomai A, de Jong YP, Rice CM, Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol. 2014;26:78–88. Epub 2014/01/25. doi: 10.1016/j.semcancer.2014.01.004 24457013; PubMed Central PMCID: PMC4048791.
29. He G, Karin M, NF-kappaB and STAT3—key players in liver inflammation and cancer. Cell research. 2011;21(1):159–68. Epub 2010/12/29. doi: 10.1038/cr.2010.183 21187858; PubMed Central PMCID: PMC3193410.
30. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431(7007):461–6. Epub 2004/08/27. doi: 10.1038/nature02924 15329734.
31. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. The Journal of clinical investigation. 2008;118(2):560–70. Epub 2008/01/26. doi: 10.1172/JCI32453 18219394; PubMed Central PMCID: PMC2213370.
32. Zaidi MR, Merlino G, The two faces of interferon-gamma in cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2011;17(19):6118–24. Epub 2011/06/28. doi: 10.1158/1078-0432.CCR-11-0482 21705455; PubMed Central PMCID: PMC3186825.
33. Schroder K, Hertzog PJ, Ravasi T, Hume DA, Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163–89. Epub 2003/10/04. doi: 10.1189/jlb.0603252 14525967.
34. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proceedings of the National Academy of Sciences of the United States of America. 1998;95(13):7556–61. Epub 1998/06/24. 9636188; PubMed Central PMCID: PMC22681.
35. Dighe AS, Richards E, Old LJ, Schreiber RD, Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity. 1994;1(6):447–56. Epub 1994/09/01. 7895156.
36. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI, et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. The Journal of experimental medicine. 2000;192(5):761–8. Epub 2000/09/07. 10974041; PubMed Central PMCID: PMC2193265.
37. Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, et al. Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer. Oncotarget. 2014;5(10):3386–98. 24930499; PubMed Central PMCID: PMC4102817.
38. Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE, Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. The Journal of biological chemistry. 2004;279(14):13677–88. Epub 2004/01/22. doi: 10.1074/jbc.M400117200 14734551.
39. Turner N, Grose R, Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010;10(2):116–29. doi: 10.1038/nrc2780 20094046.
40. Ho HK, Pok S, Streit S, Ruhe JE, Hart S, Lim KS, et al. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. J Hepatol. 2009;50(1):118–27. doi: 10.1016/j.jhep.2008.08.015 19008009.
41. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer. 1995;61(2):170–6. 7705943.
42. Sahadevan K, Darby S, Leung HY, Mathers ME, Robson CN, Gnanapragasam VJ, Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer. J Pathol. 2007;213(1):82–90. doi: 10.1002/path.2205 17607666.
43. Shah RN, Ibbitt JC, Alitalo K, Hurst HC, FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1alpha. Oncogene. 2002;21(54):8251–61. doi: 10.1038/sj.onc.1206020 12447688.
44. Asanuma S, Yamagishi M, Kawanami K, Nakano K, Sato-Otsubo A, Muto S, et al. Adult T-cell leukemia cells are characterized by abnormalities of Helios expression that promote T cell growth. Cancer Sci. 2013;104(8):1097–106. doi: 10.1111/cas.12181 23600753.
45. Jung Y, Abdel-Fatah TM, Chan SY, Nolan CC, Green AR, Ellis IO, et al. SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy. Cancer Res. 2013;73(23):6951–62. doi: 10.1158/0008-5472.CAN-13-0982 24296488.
46. Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L, Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1995;92(4):1057–61. Epub 1995/02/14. 7862633; PubMed Central PMCID: PMC42636.
47. Mitra-Kaushik S, Harding J, Hess J, Schreiber R, Ratner L, Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma. Blood. 2004;104(10):3305–11. Epub 2004/08/05. doi: 10.1182/blood-2004-01-0266 15292059.
48. Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, et al. Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One. 2009;4(8):e6517. doi: 10.1371/journal.pone.0006517 19654865; PubMed Central PMCID: PMC2715877.
49. Araya N, Sato T, Yagishita N, Ando H, Utsunomiya A, Jacobson S, et al. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease. Viruses. 2011;3(9):1532–48. Epub 2011/10/14. doi: 10.3390/v3091532 viruses-03-01532 [pii]. 21994794; PubMed Central PMCID: PMC3187691.
50. Ando H, Sato T, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, et al. Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain: a journal of neurology. 2013;136(Pt 9):2876–87. Epub 2013/07/31. doi: 10.1093/brain/awt183 23892452.
51. Livak KJ, Schmittgen TD, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. Epub 2002/02/16. doi: 10.1006/meth.2001.1262 11846609.